Breaking News, Promotions & Moves

Amarin Corp.

Colin W. Stewart has been appointed president, chief executive officer of Amarin Corp. and a member of the company's board of directors, effective August 16, 2010.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Colin W. Stewart has been appointed president, chief executive officer of Amarin Corp. and a member of the company’s board of directors, effective August 16, 2010.Mr. Stewart will be responsible for driving the company’s strategy to maximize the value of its lead product, AMR101, in Phase III trials for the treatment of high triglycerides. Results from the company’s Phase III MARINE trial are expected in early 2011. Mr. Stewart has more than 30 years of experience in executive man...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters